HBsAg, Anti-HCV, and Anti-HIV Seroprevalence Among Patients Presenting to a State Hospital between 2014 and 2018
Journal Title: Mediterranean Journal of Infection, Microbes and Antimicrobials - Year 2019, Vol 8, Issue 1
Abstract
Introduction: The epidemiology of viral hepatitis and human immunodeficiency virus (HIV) infections has been changing worldwide and in Turkey. The aim of this study was to present current information about seropositivity rates in hepatitis B surface antigen (HBsAg), anti-hepatitis C virus (HCV), and anti-HIV test results according to gender, age, and other risk factors (dialysis, preoperative tests, outpatient clinics) in patients aged 1-99 who presented to the İzmir Menemen State Hospital between January 2014 and July 2018. Materials and Methods: During the study period, 58,752 samples were tested for HBsAg, 53,649 samples for anti-HCV, and 48,162 samples for anti-HIV by chemiluminescence immunoassay method by using HBsAg 2, anti-HCV 2 and HIV combi PT kits in a Roche Modular E170 device (Roche Diagnostics GmbH, Penzberg, Germany). Data were collected retrospectively from the microbiology laboratory database. Results: The seropositivity rates for HBsAg, anti-HCV, and anti-HIV were 4.75% (2790/58,752), 0.7% (376/53,649), and 0.02% (11/48,162), respectively. The mean age of patients with HCV seropositivity was significantly higher (57±10 years) than patients with hepatitis B virus (HBV) seropositivity (41±13 years). Hepatitis B surface antigen and anti-HCV seropositivity rates were significantly higher in dialysis patients (8.7% and 10%, respectively) than in the other groups. Of the HBsAg-positive individuals, 74 (2.65%) were born between 1999 and 2007 (HBV vaccine was added to the routine vaccination program in Turkey in 1998) and only 1 (0.03%) was born after 2007 (the year that family medicine practice was implemented in İzmir province). The other 2,715 HBsAg-positive individuals (97.32%) were born in or before 1998. Conclusion: The seropositivity rates for HBsAg and anti-HCV in our region were found to be compatible with other regions. Monitoring changes in regional data and surveillance studies are important for HBV, HCV, and HIV infections and seropositivity rates.
Authors and Affiliations
Fulya BAYINDIR BİLMAN
Retrospective Evaluation of Vancomycin-resistant Enterococci Outbreak in Neonatal Intensive Care Unit
Introduction: Vancomycin-resistance in enterococci (VRE) poses a major threat in hospitals. It is well known that patients in the neonatal intensive care unit (NICU) is especially at risk of nosocomial VRE acquisition. I...
Osteoarticular Involvement and Inadequate Treatment of Brucellosis are Related to Relapse
Introduction: The goal of treatment in brucellosis is to control symptoms to prevent the development of complications and relapse of infection. The aim of this study was to evaluate the risk factors for relapse in brucel...
EDİTÖRYAL
No Abstract
Are Blood Cultures Useful in Patients with Skin and Soft Tissue Infections?
Introduction: Blood cultures are almost routinely performed in patients hospitalized with skin and soft tissue infections (SSTIs). The aim of this study was to evaluate the diagnostic importance of blood cultures in pati...
Seroprevalence and Risk Factors for Epstein-Barr Virus Infection in Adults
Introduction: Epstein-Barr virus (EBV), also known as human herpesvirus 4, is the causative agent of infectious mononucleosis. Infection with EBV is associated with multiple malignancies. The aim of this study was to det...